JIANCHAO XU, M.D., PH.D.
Osteopathic Medicine in New Haven, CT

License number
Connecticut 036656
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
950 Campbell Ave Bldg #3 ROOM E203, New Haven, CT 06516
Phone
(203) 932-5711

Personal information

See more information about JIANCHAO XU at radaris.com
Name
Address
Phone
Jianchao Xu
172 Bassett St, New Haven, CT 06511
Jianchao Xu
3 W West Walk, West Haven, CT 06516
Jianchao Xu, age 58
79 Bethany Farms Rd, Bethany, CT 06524
(203) 393-1702
Jianchao Xu
New Haven, CT
(203) 393-1702
Jianchao C Xu, age 58
79 Bethany Farms Rd, Bethany, CT 06524
(203) 393-1702

Organization information

See more information about JIANCHAO XU at bizstanding.com

Jianchao Xu MD,PHD

950 Campbell Ave, West Haven, CT 06516

Industry:
Internist
Phone:
(203) 932-5711 (Phone)
Jianchao Xu

Professional information

See more information about JIANCHAO XU at trustoria.com
Jianchao Xu Photo 1
Dr. Jianchao Xu - MD (Doctor of Medicine)

Dr. Jianchao Xu - MD (Doctor of Medicine)

Hospitals:
950 Campbell Ave SUITE 3, West Haven 06516
950 Campbell Ave SUITE 3, West Haven 06516
Education:
Residency Hospital
Hospital Of St Raphael
Yale New Haven Hospital


Jianchao Xu Photo 2
Methods Of Regulating Renalase (Monoamine Oxidase C)

Methods Of Regulating Renalase (Monoamine Oxidase C)

US Patent:
2011008, Apr 7, 2011
Filed:
Nov 15, 2010
Appl. No.:
12/946630
Inventors:
GARY DESIR - WOODBRIDGE CT, US
JIANCHAO XU - BETHANY CT, US
Assignee:
YALE UNIVERSITY - NEW HAVEN CT
International Classification:
A61K 38/44, A61K 9/14, A61P 9/00, A61P 25/00, C12N 9/02
US Classification:
424499, 424 944, 435189
Abstract:
The present invention provides methods of using Monoamine Oxidase C (MAO-C), also known as renalase, as a therapeutic protein in its active and inactive forms. Administering inactive renalase protein to individuals with lower renalase levels can be used to provide them with an adequate pool of the protein that can be activated by the body as needed. Active renalase protein can be administered to individuals needing an immediate reduction of catecholamine levels. An inhibitor of renalase may be used to enhance adrenergic action.


Jianchao Xu Photo 3
Methods Of Treatment With Renalase (Monoamine Oxidase C)

Methods Of Treatment With Renalase (Monoamine Oxidase C)

US Patent:
7858084, Dec 28, 2010
Filed:
Nov 21, 2006
Appl. No.:
11/602409
Inventors:
Gary Desir - Woodbridge CT, US
Jianchao Xu - Bethany CT, US
Assignee:
Yale University - New Haven CT
International Classification:
A61K 38/44
US Classification:
424 944, 435189, 536 232
Abstract:
The present invention provides methods of using Monoamine Oxidase C (MAO-C), also known as renalase, as a therapeutic protein in its active and inactive forms. Administering inactive renalase protein to individuals with lower renalase levels can be used to provide them with an adequate pool of the protein that can be activated by the body as needed. Active renalase protein can be administered to individuals needing an immediate reduction of catecholamine levels. An inhibitor of renalase may be used to enhance adrenergic action.


Jianchao Xu Photo 4
Compositions And Methods Relating To Glucose Metabolism, Weight Control, And Food Intake

Compositions And Methods Relating To Glucose Metabolism, Weight Control, And Food Intake

US Patent:
2003003, Feb 13, 2003
Filed:
Jun 11, 2002
Appl. No.:
10/167528
Inventors:
Gary Desir - Woodbridge CT, US
Jianchao Xu - Bethany CT, US
International Classification:
A61K048/00, A61K038/17, A61K031/47, A61K031/445, A61K031/44
US Classification:
514/012000, 514/044000, 514/019000, 514/307000, 514/313000, 514/352000, 514/355000, 514/317000, 514/419000, 514/642000
Abstract:
The present invention relates to weight control, control of body fat and food intake, and provides useful methods for treating, inter alia, obesity, diabetes and insulin insensitivity, and conditions, diseases, and disorders relating thereto. The invention also relates to methods of identifying useful compounds relating to weight loss, food intake, diabetes, and obesity, among other things, based on the discovery that inhibiting Kv1.3 activity mediates decreased food intake, weight loss, decreased body fat, increase glucose uptake, and increased insulin sensitivity, among other things.


Jianchao Xu Photo 5
Detection, Isolation And Uses Of Renalase (Monoamine Oxidase C)

Detection, Isolation And Uses Of Renalase (Monoamine Oxidase C)

US Patent:
2013027, Oct 17, 2013
Filed:
Apr 21, 2011
Appl. No.:
13/091359
Inventors:
JIANCHAO XU - BETHANY CT, US
GARY DESIR - WOODBRIDGE CT, US
Assignee:
YALE UNIVERSITY - NEW HAVEN CT
International Classification:
C12N 9/00
US Classification:
424 944, 435191, 435 74
Abstract:
The present invention provides for the identification, isolation and uses of mammalian Monoamine Oxidase C (MAO-C), also known as renalase.


Jianchao Xu Photo 6
Detection, Isolation And Uses Of Renalase (Monoamine Oxidase C)

Detection, Isolation And Uses Of Renalase (Monoamine Oxidase C)

US Patent:
7700095, Apr 20, 2010
Filed:
Mar 21, 2005
Appl. No.:
10/593099
Inventors:
Jianchao Xu - Bethany CT, US
Gary Desir - Woodbridge CT, US
Assignee:
Yale University - New Haven CT
International Classification:
A61K 38/44, C12N 9/02, C12Q 1/00, C12P 21/04, C12N 1/20, C07H 21/04, C12Q 1/68
US Classification:
424 944, 435189, 435 4, 435 6, 435 691, 435 711, 4352523, 4353201, 435440, 536 232
Abstract:
The present invention provides for the identification, isolation and uses of mammalian Monoamine Oxidase C (MAO-C), also known as renalase.


Jianchao Xu Photo 7
Detection, Isolation And Uses Of Renalase (Monoamine Oxidase C)

Detection, Isolation And Uses Of Renalase (Monoamine Oxidase C)

US Patent:
7932067, Apr 26, 2011
Filed:
Jan 28, 2010
Appl. No.:
12/695843
Inventors:
Jianchao Xu - Bethany CT, US
Gary Desir - Woodbridge CT, US
Assignee:
Yale University - New Haven CT
International Classification:
C12N 9/02, C12N 15/00, C12N 1/20, C07H 21/04, C12P 21/04, C12Q 1/00, C12Q 1/68
US Classification:
435189, 435 4, 435 6, 435 691, 435 711, 4352523, 4353201, 435440, 536 232
Abstract:
The present invention provides for the identification, isolation and uses of mammalian Monoamine Oxidase C (MAO-C), also known as renalase.